Chemoinformaics analysis of trans-2,cis-6-Nonadienal
| Molecular Weight | 138.21 | nRot | 5 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 0 |
| Exact Molecular Weight | 138.104 | nRing | 0 |
| Solubility: LogS | -7.003 | nHRing | 0 |
| Solubility: LogP | 7.998 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 25.1671 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.343 |
| Synth | 1.108 |
| Natural Product Likeliness | 0.163 |
| NR-PPAR-gamma | 0.089 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.724 |
| MDCK | 0.0000095 |
| BBB | 0.152 |
| PPB | 0.982702 |
| VDSS | 3.726 |
| FU | 0.016479 |
| CYP1A2-inh | 0.413 |
| CYP1A2-sub | 0.199 |
| CYP2c19-inh | 0.436 |
| CYP2c19-sub | 0.096 |
| CYP2c9-inh | 0.127 |
| CYP2c9-sub | 0.943 |
| CYP2d6-inh | 0.212 |
| CYP2d6-sub | 0.065 |
| CYP3a4-inh | 0.195 |
| CYP3a4-sub | 0.053 |
| CL | 4.637 |
| T12 | 0.082 |
| hERG | 0.215 |
| Ames | 0.007 |
| ROA | 0.038 |
| SkinSen | 0.947 |
| Carcinogencity | 0.038 |
| EI | 0.943 |
| Respiratory | 0.531 |
| NR-Aromatase | 0.029 |
| Antiviral | No |
| Prediction | 0.949148 |